Skip to main content
. 2021 Nov 19;115:62–69. doi: 10.1016/j.ijid.2021.11.025

Figure 4.

Figure 4

Pink lines corresponds to Umifenovir patients in the Moderate category, while blue represents the placebo category. Both sets of patients received the standard-of-care.